Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- deCODE Risk/Reward Balanced - Analyst Blog
Nov 07, 2008 06:48 PM
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM
- Analyst Comments: Immucor, UST Inc, Avanex, American Capital, deCODE, H&R Block, Equinix
Jul 01, 2008 07:34 PM
- Analyst Comments: deCODE, BorgWarner, Pride International, ChoicePoint, Metabasis Therapeutics, Owens Illinois, Cummins
May 02, 2008 02:42 PM
- NASDAQ Technical Picture - Expansion
May 02, 2008 02:01 AM
- A Speech, A Mistake And A Bunch Of Stocks Breaking Out
Apr 29, 2008 12:15 PM
- Analyst Comments: Eni S.p.A, Trubion Pharmaceuticals, Canon, Companhia Brasileira, deCODE
Mar 14, 2008 10:06 PM
- Earnings Summary: Wednesday, March 12, 2008
Mar 13, 2008 02:18 AM
- Nice write up on Illumina (ILMN)
Dec 20, 2007 04:35 PM
- DCGN Likely to Trend Sideways
Nov 06, 2007 02:19 PM
- Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
Nov 11, 2008 03:48 PM
- deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
Nov 10, 2008 10:29 AM
- deCODE genetics Announces Third Quarter 2008 Financial Results
Nov 06, 2008 04:28 PM
- deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
Oct 28, 2008 03:13 PM
- deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business
Oct 15, 2008 04:01 PM
- deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
Oct 13, 2008 08:43 AM
- deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer
Oct 08, 2008 08:00 AM
- deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer
Oct 08, 2008 12:01 AM
- deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Oct 03, 2008 11:00 AM
- deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
Sep 14, 2008 01:30 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
DCGN
|
Compare to S&P
|
| YTD |
-93.48 %
|
-89.32 %
|
| 4 Weeks |
-11.11 %
|
-3.92 %
|
| 12 Weeks |
-78.76 %
|
-70.56 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 3.33 %
|
|
EPS Growth in Last Year: 27.50 %
|
|
Sales Growth in Last Quarter: -20.28 %
|
|
Sales Growth in Last Quarter: 9.97 %
|
|
|
